CLGN News and Press, CollPlant Holdings Ltd. From 05/30/25

2025-05-30 07:34:25 ET CollPlant Biotechnologies ( NASDAQ: CLGN ) said Friday that it will undertake a registered direct offering and concurrent private placement to raise $3.6 million.... Read the full article on Seeking Alpha For further details see: CollPlant ...

COLLPLANT BIOTECHNOLOGIES ANNOUNCES $3.6 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES PR Newswire REHOVOT, Israel , May 30, 2025 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company...

2025-05-28 07:01:23 ET More on CollPlant Biotechnologies CollPlant Biotechnologies Ltd. (CLGN) Q4 2024 Earnings Call Transcript Collplant plans clinical trials for dermal filler and advances regenerative implants Seeking Alpha’s Quant Rating on CollPlant Biote...

Nutanix Inc. (NTNX) is expected to report $0.08 for Q3 2025 Correlate Energy Corp. (CIPI) is expected to report for quarter end 2025-03-31 HP Inc. (HPQ) is expected to report $0.8 for Q2 2025 Reservoir Media Inc.. (RSVR) is expected to report $0.04 for Q4 2025 National Bank Of Can...

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE PR Newswire - In Q1 following a development achievement, CollPlant received a $2 million payment from AbbVie – - Advancement of regenerative breast implant...

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FIRST QUARTER FINANCIAL RESULTS PR Newswire REHOVOT, Israel , May 14, 2025 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and...

2025-05-09 12:31:58 ET More on Health Care Select Sector SPDR® Fund ETF: XLV Vs. VHT: I Prefer XLV For Its Better Downturn Resilience XLV: My Method For Navigating These Pullbacks India proposes zero-for-zero tariff deal on U.S. auto parts, steel - report ...

CollPlant's Collink.3D® BioInks and Technologies Offer a Relevant and Timely Solution to FDA's Plan to Reduce Animal Testing in Preclinical Safety Studies PR Newswire CollPlant's novel rhCollagen BioInks are an available solution aligned with FDA's plan announced last wee...

2025-03-26 19:59:08 ET More on CollPlant Biotechnologies CollPlant Biotechnologies Ltd. (CLGN) Q4 2024 Earnings Call Transcript Seeking Alpha’s Quant Rating on CollPlant Biotechnologies Historical earnings data for CollPlant Biotechnologies Financial i...

2025-03-26 19:58:48 ET CollPlant Biotechnologies Ltd. (CLGN) Q4 2024 Earnings Conference Call March 26, 2025, 10:00 AM ET Company Participants Dory Kurowski - LifeSci Advisors Yehiel Tal - CEO Eran Rotem - Deputy CEO and CFO Conference Call Participants ...